HIV-1 infection is complicated not infrequently by a number of sequelae that may involve the central and peripheral nervous systems even in the absence of opportunistic infections and neoplasms. Chief among these disorders are AIDS dementia complex, vacuolar myelopathy, peripheral neuropathy and myopathy as well as other less well appreciated complications such as seizures and transient ischaemic attacks.' This review will explore the various possible explanations of such complications after a brief discussion of each entity.
Aids dementia complex (ADC)
This complication is known under a variety of terms such as HIV-1 encephalopathy, subacute encephalitis, AIDS related dementia and more recently HIV-1 associated cognitive/ motor deficit.2 To understand various pathogenetic considerations it is first necessary to outline the critical features of the disorder: its broad clinical features, the timing of the dementia, the results of investigations and the effects of treatment.
While some controversy exists as to whether the disorder is consistently a cortical or subcortical dementia because of the recent demonstration of cortical neuronal loss,35 the clinical (rather than pathological) presentation of the patients is dominantly that of a subcortical process where there are complaints of poor concentration, disturbed short term memory, slowing of thought processes with motor incoordination and gait unsteadiness. 6 Behavioural symptoms such as social apathy and withdrawal are less common and have a correlation with the severity of ADC that is similar to other disturbances such as limb tremor and urinary urgency (unpublished data). So called cortical symptoms such as aphasia, alexia and agraphia are distinctly unusual in ADC and when they do occur, they do so at an advanced stage of dementia where the deficit has become more global. ADC is most often a complication occurring at the phase of moderately advanced immunosuppression. In a personally examined group of ADC patients, the mean CD4 cell count was 94 , SD 139 (unpublished data). Numerous other investigators have also observed its relatively late occurrence. Investigations often reveal a number of abnormalities that are confirmatory of the diagnosis rather than diagnostic. Computed tomography (CT) of the brain often shows cerebral atrophy and magnetic resonance imaging of the brain may show periventricular T2 weighted abnormalities. 78 Single photon emission computed tomography (SPECT) usually shows multifocal cortical and subcortical areas of hypoperfusion.9 Preliminary data suggest that SPECT is more sensitive than the other imaging techniques'0; however, similar changes may occur very frequently in asymptomatic patients." At a more investigational level, positron emission tomography reveals hypometabolism of the basal ganglia early in the disease only to be replaced by global hypoactivity late in the illness. '2 Similarly, water This finding correlates with the presence of significant ADC. Rarely, the pathology may be characterised by vacuolation throughout the white matter which has been termed vacuolar leukoencephalopathy, the clinical correlate of which has yet to be delineated. Lastly, cerebral vasculitis has been described4849 but it would appear to be distinctly uncommon. The relationship between cortical atrophy with neuronal loss3-5 and the above neuropathological sets is presently unclear although it is most likely associated with HIV diffuse poliodystrophy and HIV encephalitis. Moreover the precise interrelationships between the latter mentioned sets is unknown but it would seem that leukoencephalopathy forms a base upon which are added the changes of diffuse poliodystrophy and in moderate to severe cases of ADC, HIV encephalitis. The overriding principle, however, is that the neuropathological changes are dominantly subcortical and even within these subcortical areas there appears to be certain structures that are more commonly involved. Thus several investigators have noted the prominent basal ganglia involvement, especially the globus pallidus. 45 50 Importantly, at least two researchers have noted that the distribution of pathology is inconsistent with a simple "centrifugal" spread of disease from the meninges.4045
ADC can be treated successfully with zidovudine and possibly other nucleosides. While there is some controversy as to the optimal dose of ZDV for ADC there is no doubt that it improves and sometimes reverses cognitive impairment.515' Similarly, there is some evidence for the efficacy of didanosine at least in children54 although preliminary analysis of the efficacy of didanosine in adults has cast some doubt as to whether there is any significant effect (Portegies, personal communication). However, despite the encouraging reports of treatability of ADC it must be recognised that not all patients will respond to therapy even with zidovudine. The explanation for such variation in response is unknown but it may relate to resistance to the particular drug, inadequate penetration of the drug through the blood brain barrier and possibly the nature of a particular strain of virus; for example, the syncytium inducing virus strain is purported to be relatively insensitive to zidovudine or to develop drug resistance more rapidly. 55 Furthermore, the precise neuropathological features of ADC that may or may not respond to treatment are unknown save for preliminary data showing that multinucleated cell changes and HIV leukoencephalopathy have become less frequent since the introduction of zidovudine. 56 57 With the latter background, it is possible to approach some pathogenetic considerations of HIV-1 brain involvement that serve as a base for the construction of a theoretical model. Firstly, subclinical involvement of the nervous system is common throughout the long course of HIV-1 infection as delineated by a number of investigators approaching the issue from different aspects. Minor neuropsychological dysfunction has been found by several groups in the absence of any symptoms5859 while other larger studies have not shown any significant deficit at a population level.7606' Frequent abnormalities in the CSF of asymptomatic patients have also been described with a mild mononuclear pleocytosis usually of less than 100 mononuclear cells, an elevated protein'6 and recovery of HIV-1 from the CSF in a small percentage of patients and rarely p24, the core protein of HIV-1. 89 The mechanism by which HIV-1 actually enters the brain is still conjectural but there are at least two possibilities, namely through trafficking of activated T cells, the so called "Trojan horse" mechanism,90 91 since these have been shown to be able to cross the blood-brain barrier. As well, since the blood brain barrier is disrupted in advanced HIV-1 disease92 93 98 Our group has also shown that quinolinic acid, an N-methyl D-aspartate receptor agonist, is elevated in the CSF of ADC patients23 and that in vitro HIV-1 infected macrophages can produce large quantities of quinolinic acid with this production being dependent upon the degree of macrophage tropism of HIV-1.99 100 While these mechanisms serve to assist in understanding the pathogenesis of neuronal loss and dysfunction, they do not address the causation of the leukoencephalopathy. At present, it seems likely that the cerebral white matter is affected by the cytokines that are released by macrophage lineage cells in an attempt to control infection. Certainly similar leukoencephalopthic changes have been observed in patients receiving high doses of various cytokines as part of cancer chemotherapy. Another possible mechanism is the documented methylation defect'0' in HIV-1 infected individuals that may lead to changes similar to cyanocobalamin deficiency. The third possibility, namely direct infection of oligodendrocytes, would seem to be unlikely as previously discussed and if present to be of minor significance.
Vacuolar myelopathy Approximately one third of patients'02 have a myelopathy usually manifesting as a spastic paraparesis without a definite sensory level although posterior column type sensory loss namely, proprioception and vibration disturbance is prominent. The disorder is largely confined to the legs and has a subacute to chronic onset over weeks to months leading on occasion to a wheelchair bound state. In most patients the myelopathy is associated with ADC. Importantly, vacuolar myelopathy is exceptionally uncommon in children who are HIV-1 infected.'03
Pathologically there are multiple vacuoles in the white matter of the posterior and lateral columns of the spinal cord, infrequent lipid-laden macrophages and separation of the myelin lamellae on electron microscopy. Despite the similarities with subacute combined degeneration of the cord serum vitamin B12 levels are normal. Recent studies have demonstrated that this disorder is probably not the result of productive HIV-1 infection'04 105 The latter neuropathies have been studied pathologically and the consistent finding has been the lack of evidence of significant productive infection of the peripheral nerve"8 120; the only exception being a patient who had productive infection in endoneural infiltrates. Consequently, the pathogenesis of these neuropathies is considered most likely to be on an autoimmune basis. "15 An autonomic neuropathy has also been described.'2' Its clinical manifestations of bladder and bowel dysfunction, sweating abnormalities and arrhythmias occur infrequently although a subclinical autonomic neuropathy has been found in up to 50% of HIV infected patients.'22 Because this neuropathy often occurs in conjunction with the distal symmetrical predominantly sensory neuropathy, pathogenetic possibilities for both disorders will be discussed together.
Probably the most important of the HIV related peripheral neuropathies is the distal predominantly sensory neuropathy. This is largely a feature of advanced HIV disease and is common occurring in approximately 45% of such patients.123 124 Patients complain of numbness which is usually confined to the lower legs; only rarely are the arms involved. Significant weakness of the legs is distinctly unusual. In a small proportion of patients a painful distal sensory neuropathy develops which advances to the point where walking is difficult. '25 The pathogenesis of these neuropathies is also unclear. Productive infection of the nerve has not been convincingly demonstrated'05 126 and although cytomegalovirus infection has been implicated in the pathogenesis of the distal painful sensory peripheral neuropathy on epidemiological grounds'27 it is unlikely that cytomegalovirus is playing a significant role when one considers that the neuropathy may occur at a time when there is insufficient immunodeficiency for cytomegalovirus to be a pathogen. The significance of the rarity of peripheral neuropathy in HIV infected children is unknown but as with vacuolar myelopathy it may point to an indirect pathogenesis perhaps a metabolic disturbance or another opportunistic infection. A metabolic aetiology has support by way of the previously mentioned methylation defect that has been found in HIV infected patients. In a similar disturbance, abuse of nitrous oxide, the resulting methylation defect leads to a peripheral neuropathy and myelopathy.'28 However, macrophages have been found to be prominent in the peripheral nerves of HIV infected patients arguing against a purely metabolic disturbance. 129 Myopathies HIV-1 related myopathy is still a poorly defined entity. Patients usually present with slowly progressive proximal weakness that seemingly may occur at any point in their HIV-1 disease. Excluding zidovudine related myopathy the pathological findings can be grouped as follows: an inflammatory myopathy that is similar to if not identical with polymyositis and a non-inflammatory myopathy.130 131 Pathogenetically, productive HIV-1 infection has not been found in the majority of studies with the exception of occasional evidence of infection of the infiltrating cells."5 Such data would seem to point away from a direct HIV-1 aetiology.
Seizures
Seizures may also complicate HIV-1 infection.'32 133 They may be both partial and generalised although this author's experience is that they are most often generalised. Preliminary data indicate that they are largely a feature of moderately advanced HIV-1 disease and that there is an association with ADC (6, 
